Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Techne Cp
(NQ:
TECH
)
348.50
+2.49 (+0.72%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 29, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
222,774
Open
345.27
Bid (Size)
346.55 (6)
Ask (Size)
554.48 (1)
Prev. Close
346.01
Today's Range
341.55 - 349.49
52wk Range
318.07 - 543.85
Shares Outstanding
39,233,511
Dividend Yield
0.37%
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Tackling Recurring Health Conditions Offers Hope to Patients
June 21, 2022
Palm Beach, FL – June 21, 2022 – FinancialNewsMedia.com News Commentary – Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly...
Via
FinancialNewsMedia
7 Defensive Growth Stocks to Buy for a Shaky Market
May 21, 2022
These are the best defensive growth stocks to invest in now. Each of these can make great investments if/when the market sours.
Via
InvestorPlace
Performance
YTD
-28.56%
-28.56%
1 Month
-5.74%
-5.74%
3 Month
-21.86%
-21.86%
6 Month
-29.99%
-29.99%
1 Year
-21.68%
-21.68%
More News
Read More
7 Superior Stocks That Smart Investors Will Buy on the Dip
February 07, 2022
Via
InvestorPlace
Bio-Techne Clocks 17% Organic Revenue Growth In Q2, Announces $400M Share Buyback
February 01, 2022
Via
Benzinga
Earnings Scheduled For November 2, 2021
November 02, 2021
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
June 14, 2022
Via
Benzinga
Recap: Bio-Techne Q3 Earnings
May 04, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
April 25, 2022
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
February 02, 2022
Via
Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
February 01, 2022
Via
Benzinga
Here's How Much You Would Have Made Owning Bio-Techne Stock In The Last 5 Years
December 03, 2021
Via
Benzinga
Bio-Techne Corporation (TECH) Q1 2022 Earnings Call Transcript
November 02, 2021
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US
November 02, 2021
Via
Benzinga
Exposures
COVID-19
Bio-Techne's Earnings: A Preview
November 01, 2021
Via
Benzinga
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
September 16, 2021
Via
Benzinga
A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Data; Crude Oil Gains 1%
September 15, 2021
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Via
Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Via
Benzinga
Exposures
COVID-19
Director Of Bio-Techne Trades $4.80 Million In Company Stock
September 09, 2021
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
CFO Of Bio-Techne Trades $6.14 Million In Company Stock
September 08, 2021
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself
September 03, 2021
Via
Benzinga
Bio-Techne Corporation (TECH) Q4 2021 Earnings Call Transcript
August 05, 2021
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks That Hit 52-Week Highs On Thursday
August 05, 2021
Via
Benzinga
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Via
Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.